July 27, 2025 - 09:11

Good morning, Newport! 🗓️ Today is Saturday, July 26, the 207th day of 2025. There are 158 days left in the year.
Exciting developments are on the horizon as the 401 Tech Bridge prepares to host BlueTIDE 2025, a premier maritime technology demonstration event. Scheduled for Thursday, August 28, this event will take place from 10:30 a.m. to 6 p.m. at Sail Newport.
BlueTIDE 2025 aims to spotlight cutting-edge innovations in maritime technology, bringing together industry leaders, researchers, and enthusiasts to explore advancements that could shape the future of ocean exploration and sustainability. Attendees will have the opportunity to witness live demonstrations of state-of-the-art technologies designed to enhance maritime operations, improve safety, and promote environmental stewardship.
This event not only serves as a platform for showcasing these innovations but also fosters collaboration and dialogue among key stakeholders in the maritime sector. As the event approaches, excitement continues to build within the community, highlighting Newport's role as a hub for maritime advancements.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...